Publication | Closed Access

Haploidentical hematopoietic SCT may be superior to conventional consolidation/maintenance chemotherapy as post-remission therapy for high-risk adult ALL

Hematological MalignancyOncologyMalignant Blood DisorderHematologyHigh-risk Adult AllHaploidentical Hematopoietic SctMedicineRadiation OncologyConventional Consolidation/maintenance ChemotherapyHealth Sciences